Debate Series - Estro-events.org
Debate Series - Estro-events.org
Debate Series - Estro-events.org
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
sCiEnTiFiC proGrAMME<br />
Saturday 12 May 2012<br />
CliniCal inTERdiSCiPlinaRy PhySiCS RadiObiOlOgy RTT yOung<br />
Page 156 PROgRammE & ExhibiTiOn guidE • ESTRO 31<br />
abS. numbER<br />
SYMPOSIUM<br />
noVEl CliniCAl sTrATEGiEs To rEdUCE norMAl TissUE inJUiry<br />
lEaRning ObJECTivES:<br />
The session will cover the major axis of research ongoing in the field of normal tissue<br />
protection, from stem cell therapy to new targeted approaches (monoclonal antibodies)<br />
08:45 - 10:00 • Room 120-121<br />
ChaiR: M. Vozenin (France)<br />
CO-ChaiR: S. Benavente (Spain)<br />
08:45 > Stem cell therapy to ameliorate radiation damage in salivary glands<br />
SPEaKER: R. Coppes (The Netherlands) SP-0432<br />
09:10 > Attenuation and reversion of radiation induced fibrosis by<br />
an anti CTGF monoclonal antibody<br />
SPEaKER: P. Huber (Germany) SP-0433<br />
09:35 > Novel clinical approaches to reduce brain radiation injury<br />
SPEaKER: R. Tarnawski (Poland) SP-0434<br />
SYMPOSIUM<br />
rAdiobioloGy prinCiplEs: dosE FrACTionATion<br />
lEaRning ObJECTivES:<br />
To provide knowledge and skills to:<br />
1. Understand how different fractionation regimens can influence tumors and the OARs<br />
2. Identify pros and cons of radiobiological strategies<br />
3. Promote the efficacy of different radiation schemes on specific treatment sites<br />
08:45 - 10:00 • Room 118-119<br />
ChaiR: F. Moura (Portugal)<br />
CO-ChaiR: J.F. Calvo Ortega (Spain)<br />
08:45 > Radiobiological principles: what the RTT needs to know know»<br />
SPEaKER: M. Mangoni (Italy) SP-0435<br />
09:03 > Hyperfractionation: radiobiological basis for clinical practice<br />
SPEaKER: T. Rutkowski (Poland) SP-0436<br />
Saturday 12 May 2012<br />
abS. numbER<br />
09:21 > Accelerated treatment in breast cancer<br />
SPEaKER: P. Koper (The Netherlands) SP-0437<br />
09:39 > Hypofractionation: general overview<br />
SPEaKER: J.R. Yarnold (United Kingdom) SP-0438<br />
POSTER DISCUSSION: 9<br />
hEAd And nECK<br />
09:00 - 09:45 • Poster Area<br />
ChaiR: N. Di Muzio (Italy)<br />
CO-ChaiR: E.M. Ozsahin (Switzerland)<br />
> CTV margin in laryngeal and hypopharyngeal cancer: a histology study<br />
J. Caldas-Magalhaes (The Netherlands), N. Kooij, N. Kasperts,<br />
F.A. Pameijer, C.H.J. Terhaard, C.P.J. Raaijmakers,<br />
M.E.P. Philippens Pd-0439<br />
> The influence of tumor growth rate in laryngeal cancer on<br />
disease free survival<br />
L.W. van Bockel (The Netherlands), E.M. Monninkhof,<br />
C.H.J. Terhaard Pd-0440<br />
> Target volume delineation based on 18FDG PET for locally<br />
advanced head and neck cancer treated by chemo-radiotherapy<br />
M. Leclerc (Belgium), E. Lartigau, T. Lacornerie, J. Daisne,<br />
V. Grégoire Pd-0441<br />
> Hypothyroidism after head and neck 3DCRT and IMRT:<br />
prospective data from two randomized trials<br />
V. Murthy (India), K. Narang, J.P. Agarwal, S. Ghosh-Laskar,<br />
T. Gupta, A. Budrukkar Pd-0442<br />
> Pattern of loco-regional recurrences after primary IMRT of<br />
squamous cell carcinomas of the head and neck<br />
R. Zukauskaite (Denmark), C.R. Hansen, J.T. Asmussen,<br />
C. Brink, J. Johansen, J.G. Eriksen Pd-0443<br />
ESTRO 31 • PROgRammE & ExhibiTiOn guidE Page 157<br />
sCiEnTiFiC proGrAMME<br />
eSTRO 31
Change language